文献速递肿瘤 PET/CT核素与放射性配体治疗

肝细胞癌90Y-SIRT后18F-FDG与68Ga-FAPI-04 PET/CT显像

18 F-FDG and 68 Ga-FAPI-04 PET/CT Imaging in a Patient With Hepatocellular Carcinoma After 90 Y-SIRT.
PubMed 文献 · Clin Nucl Med · 2026-04-29

本文报道一名52岁肝细胞癌患者在接受钇-90选择性内放射治疗(90Y-SIRT)后3周行18F-FDG和68Ga-FAPI-04 PET/CT显像的结果。存活肿瘤及右门静脉癌栓均显示轻至中度18F-FDG摄取,而瘤周组织显示高68Ga-FAPI-04摄取,其范围与90Y SPECT/CT上放射性示踪剂分布大致匹配。提示在90Y-SIRT早期监测中,18F-FDG PET/CT识别存活肝细胞癌肿瘤优于68Ga-FAPI-04 PET/CT,而68Ga-FAPI-04 PET/CT可间接勾画90Y-SIRT区域。

要点

  • 90Y-SIRT后3周,存活肝细胞癌及门静脉癌栓呈轻至中度18F-FDG摄取。
  • 瘤周组织高68Ga-FAPI-04摄取范围与90Y SPECT/CT示踪分布大致匹配。
  • 早期90Y-SIRT监测中,18F-FDG PET/CT识别存活肿瘤优于68Ga-FAPI-04 PET/CT。

核心结论

  • 在90Y-SIRT早期监测中,18F-FDG PET/CT识别存活肝细胞癌肿瘤优于68Ga-FAPI-04 PET/CT。
  • 68Ga-FAPI-04 PET/CT可间接勾画90Y-SIRT的区域。

研究设计与样本

  • 病例报告:一名52岁男性肝细胞癌患者在90Y-SIRT后3周行18F-FDG和68Ga-FAPI-04 PET/CT显像。

主要发现

  • 存活肿瘤及右门静脉癌栓均显示轻至中度18F-FDG摄取。
  • 瘤周组织显示高68Ga-FAPI-04摄取,其范围与90Y SPECT/CT上放射性示踪剂分布大致匹配。

临床怎么用

  • 90Y-SIRT早期监测可优先采用18F-FDG PET/CT识别存活肝细胞癌肿瘤。
  • 68Ga-FAPI-04 PET/CT可用于间接勾画90Y-SIRT区域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 18 F-FDG and 68 Ga-FAPI-04 PET/CT imaging findings were reported in a 52-year-old man with hepatocellular carcinoma (HCC) 3 weeks after undergoing yttrium-90 selective internal radiation therapy ( 90 Y-SIRT). Both viable tumors and tumor thrombus of right portal vein showed mild-to-moderate 18 F-FDG uptake, while peritumoral tissues showed high 68 Ga-FAPI-04 uptake, the range of which approximately matched radiotracer distribution on 90 Y SPECT/CT. Our findings indicate that 18 F-FDG PET/CT is superior to 68 Ga-FAPI-04 PET/CT for identifying viable HCC tumors during early 90 Y-SIRT monitoring, whereas 68 Ga-FAPI-04 PET/CT indirectly delineates the area of 90 Y-SIRT.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Luo Y, Zhu D, Li J, et al. 18 F-FDG and 68 Ga-FAPI-04 PET/CT Imaging in a Patient With Hepatocellular Carcinoma After 90 Y-SIRT. Clin Nucl Med. 2026. PMID: 42113561. doi:10.1097/RLU.0000000000006412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。